Full-Time

Clinician

Ottobock

Ottobock

1,001-5,000 employees

Global prosthetics, orthotics, and mobility devices

No salary listed

Mesa, AZ, USA

In Person

Bachelor's, Master's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Microsoft Office
Patient Care
Marketing
HIPAA

Get referred to Ottobock

See people who can refer or advise you

Requirements
  • A minimum of 3-5 years of experience in orthotics and/or prosthetics, with a heavy prosthetics focus, is preferred.
  • Certification by the American Board for Certification in Orthotics and Prosthetics (ABC) in good standing is required.
  • A Bachelor’s degree or Master’s degree in Orthotics and/or Prosthetics is required.
  • Advanced computer skills and knowledge of Microsoft Office and databases are required.
  • The ability to communicate clearly, orally and in writing, and work effectively with vendors, suppliers, co-workers, management, and other people is required.
  • The ability to work collaboratively and participate in a team approach is required.
  • Excellent organizational and time-management skills, including prioritizing and managing multiple tasks to completion, are required.
  • The ability to anticipate, identify, analyze, and resolve conflicts and problems is required.
  • A valid driver’s license without limitations on operating a motor vehicle and a reliable vehicle are required.
  • In states where licensure is required, the ability to obtain and maintain state licensure may be required.
Responsibilities
  • Deliver high-level neuromobility orthotics, prosthetics, and professional services related to patient care.
  • Formulate designs for prosthetic and orthotic devices.
  • Provide complete and accurate direction and guidance to technicians responsible for fabricating patient orthoses and prostheses.
  • Fabricate devices as needed to ensure quality, fit, function, timely delivery, and responsiveness to individual patient needs.
  • Perform fitting, including static and dynamic alignments.
  • Evaluate prosthetic and orthotic devices on patients, adjust them to ensure fit, function, medical efficacy, and quality of work, and perform outcome measures as appropriate.
  • Instruct patients in the use of devices.
  • Provide post-delivery service and adjustments for assigned patients.
  • Provide information to administrative staff to conduct reimbursement activities.
  • Maintain current and complete patient charts and records of care and service each day.
  • Train technicians, residents, and other clinicians as appropriate.
  • Develop a referral and client base that contributes profitably to the practice’s ability to serve patients, referral sources, and employees.
  • Market the organization’s professional services by developing strong professional relationships with physicians, therapists, patients, and other referral sources.
  • Maintain the professional knowledge and technical skills required for the role, including current knowledge of procedures, components, and materials and their application based on diagnosis.
  • Identify and create process improvements to promote efficiency and productivity.
  • Adhere to safety regulations, Medicare and other governmental regulations, bloodborne pathogen requirements, and Occupational Safety and Health Administration requirements.
  • Comply with Corporate Compliance and Health Insurance Portability and Accountability Act responsibilities.
  • Perform other assigned duties and special projects.
  • Support other clinics as needed.
Desired Qualifications
  • Three to five years of experience in orthotics and/or prosthetics, with a heavy prosthetics focus.

Ottobock designs and sells prosthetics, orthotics, wheelchairs, and exoskeletons to help people with mobility impairments move more independently. Its microprocessor-controlled prosthetics use sensors and actuators to adapt to gait and improve balance, while ergonomic exoskeletons support movement for users with limited strength. Its family-owned heritage since 1919, global reach in about 60 countries, and partnerships like the Paralympic Games set it apart through a focus on quality and social responsibility. Its goal is to improve mobility and independence by delivering reliable assistive technologies and supporting inclusion in daily life and sport.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Duderstadt, Germany

Founded

1919

Get referred to Ottobock

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 core revenue rose 7.7% to €818.5 million, with EBITDA margin at 25.3%.
  • Ottobock narrowed 2026 guidance on August 13, 2026, signaling stronger demand and operating leverage.
  • The July 2026 Fesia deal and Blue Arbor investment deepen the neuro-orthotics pipeline immediately.

What critics are saying

  • Grizzly Research’s May 2026 report triggered legal threats and BaFin scrutiny over Russia allegations.
  • The June 2026 Human Mobility sale shrinks revenue breadth and risks execution slippage before H2 2026.
  • Hans Georg Näder’s control keeps governance and reputational risk concentrated; an adverse probe can crush the IPO.

What makes Ottobock unique

  • Ottobock dominates prosthetics and neuro-orthotics, pairing devices with clinics across nearly 60 countries.
  • Its FES and exoskeleton platforms combine hardware, software, and patient-care services into sticky workflows.
  • Blue Arbor and Fesia extend Ottobock into implanted control and functional electrical stimulation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

100% company-paid short & long-term disability

Company News

PR Newswire
Jul 22nd, 2026
Ottobock releases community-built AI image library to improve representation of people with limb loss

Ottobock has released the #DearAI Community Library, one of the first open-source image datasets depicting people with limb loss and limb differences in everyday life. The library, powered by Microsoft and now available on Hugging Face, was created and annotated by the community itself to address AI's lack of disability representation. Research across 444 AI-generated images found not a single person with visible disability appeared in 37 occupations. When disability does appear, nearly 100% default to wheelchair depictions, making prosthetic users effectively invisible. An international group of Ottobock prosthetic users worked within Microsoft's Community Library Creator to select and annotate images against community-defined standards. The result includes two datasets covering upper and lower limb differences, showing people as parents, colleagues, athletes and community members. The library is freely accessible to researchers, developers, brands and creators at huggingface.co/ottobock.

AD HOC NEWS
Jul 7th, 2026
Ottobock acquires Spain's Fesia Technology to expand neuro-orthotics portfolio with FES systems

German MedTech company Ottobock is acquiring Spanish firm Fesia Technology to expand its neuro-orthotics portfolio. The deal, expected to close in approximately six months, will add functional electrical stimulation (FES) technology to Ottobock's product range. Financial terms were not disclosed. Fesia, based in Donostia/San Sebastián, employs around 20 people and develops FES systems for patients with neurological conditions including stroke, multiple sclerosis, cerebral palsy, and spinal cord injuries. The technology uses electrical impulses to stimulate weakened muscles and support the formation of new neural connections. Ottobock CEO Oliver Jakobi said neurological conditions are a major focus for the orthotics and prosthetics industry, with the number of affected people steadily increasing worldwide. The acquisition strengthens Ottobock's position as a global leader in neuro-orthotics whilst providing access to an innovative FES technology platform.

Yahoo Finance
May 14th, 2026
Ottobock's $268M free cash flow exceeds $104M profit amid strong earnings

Ottobock SE KGaA reported solid earnings supported by strong cash flow conversion. The company generated €237 million in free cash flow over the past twelve months, significantly exceeding its statutory profit of €91.8 million. The company's accrual ratio of -0.11 for the year to March 2026 indicates its free cash flow substantially surpassed reported earnings, which analysts consider a positive sign. However, unusual items worth €30 million reduced Ottobock's profit during the period. These one-time expenses contributed to the strong cash conversion metrics but are not expected to recur. Analysts suggest that without these unusual charges, Ottobock should deliver higher profits in the coming year, assuming other factors remain constant.

Morningstar
Feb 26th, 2026
Blue Arbor secures $5M from Ottobock to advance FDA breakthrough prosthetic control system

Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.

Business Wire
Feb 26th, 2026
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System

Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control